Press
-
SRI board member and astronaut Ellen Ochoa: Pushing the boundaries of science
Ochoa logged nearly 1,000 hours in space, received the Presidential Medal of Freedom, and was inducted into the U.S. Astronaut Hall of Fame.
-
SRI selected as DARPA’s Regional Commercial Accelerator
DARPA looks to harness SRI’s expertise to speed up tech transition — out of the lab into the real world — and scale DARPA-funded technologies for U.S. national and economic security outcomes.
-
SRI imagers will help map the cosmos
Researchers from SRI’s Center for Advanced Imaging will help design and build the next generation of space imagers for NASA’s Ultraviolet Explorer telescope.
-
SRI appoints Peter Marcotullio as Senior Vice President of Commercialization
SRI bolsters the leadership team to deliver cutting-edge research into commercial products and services, driving growth and innovation across various industries.
-
PARC Forum: How innovation can save the living ocean
SRI, in collaboration with Stanford’s Doerr School of Sustainability, hosted the Monterey Bay Aquarium to discuss ocean conservation.
-
Researchers assess EV industry workforce potential in Northeast Ohio
A new study by SRI examines the readiness of a historic manufacturing base to support the transition to EV battery manufacturing.
-
SRI collaborates with the Acquisition, Technology & Logistics Agency, Japan Ministry of Defense, to accelerate advanced research
Japan’s new Defense Innovation Science and Technology Institute (DISTI) aims to solve complex research problems and accelerate emerging technologies into use.
-
Podcast: Supporting and empowering STEM students in community college
SRI’s Andrea Beesley and Carol Tate discuss a national initiative aimed at supporting underrepresented students.
-
The naked mole rat may hold the key to new treatments for neurodegenerative diseases
SRI researchers study the cells of the long-living rodent to find new drug targets for Alzheimer’s, Parkinson’s, and other neurodegenerative disorders.
-
Engineered helper T cell could become a cancer killer
SRI scientists are developing a cell-based platform using an often-undervalued subset of helper T cells to deliver potent antitumor proteins for solid tumors, overcoming dose-related toxicities.
-
SRI spins out Ravenswood Solutions
Ravenswood delivers high-fidelity training experiences to improve military readiness and performance.
-
Building the next generation of electronics
SRI’s cleanroom offers clients the ability to develop new devices, build prototypes, work with experts, and run small-scale manufacturing.